Ipamorelin
Selective Growth-Hormone Secretagogue
- Form
- Lyophilized powder
- Storage
- -20°C (lyophilized)
- Origin
- USA lab
from$69
Ipamorelin is a synthetic peptide reference material used in laboratory investigations of ghrelin-receptor activity and growth-hormone-secretagogue signaling.
- Ghrelin-receptor binding research
- Growth-hormone-secretagogue signaling studies
- Receptor selectivity and pathway-response models
SKU: AP-IPAMORELIN-5MG
3 vial minimum per order — mix any products
Research Use Only
All products are intended solely for laboratory research and are not for human or animal consumption. By purchasing, the buyer agrees to use these products in compliance with all applicable laws.
Reconstitution ReferenceOptional — how strong is the mixed vial?
Mixing a powder vial with water? Fill in the fields — results update as you type.
Mixing 5 mg of peptide into 2 mL of water makes a 2.5 mg/mL solution. Each 0.1 mL contains 0.25 mg.
Reference for in-vitro laboratory handling only. Outputs describe the physical properties of the reconstituted vial (concentration and mass drawn) — they are not dosing guidance, administration instructions, or medical advice. Verify all measurements independently.
The science behind Ipamorelin
A structured overview of the published literature surrounding Ipamorelin as a selective growth-hormone-secretagogue research peptide.
Ipamorelin is a synthetic pentapeptide that acts as a selective agonist of the ghrelin receptor (growth-hormone secretagogue receptor, GHS-R). It is studied as a reference material for secretagogue-signaling research.
The peptide is valued in the research literature for its receptor selectivity relative to earlier secretagogues, making it a useful pharmacology tool.
The material supplied here is a laboratory reference standard, and the summaries below describe only findings reported in published research.
Ipamorelin was developed from research into growth-hormone secretagogues, engineered for selectivity at the ghrelin receptor with minimal off-target activity in experimental systems.
The literature includes preclinical pharmacology and cellular receptor-signaling studies examining growth-hormone-secretagogue pathways.
The primary mechanism studied is agonism at the ghrelin receptor (GHS-R1a), reported to activate phospholipase-C signaling and stimulate growth-hormone release from pituitary-cell models.
Researchers emphasize its selectivity profile, studying minimal reported activity on cortisol- and prolactin-signaling relative to earlier secretagogues.
Ghrelin-receptor assays
Used as a selective reference agonist in GHS-R1a activation studies.
Secretagogue signaling
Examined in pituitary-cell growth-hormone-release models.
Receptor-selectivity research
Studied for its selectivity relative to other secretagogues.
Comparative pharmacology
Referenced alongside other GHS-R agonists.
What is Ipamorelin?
A synthetic selective ghrelin-receptor agonist pentapeptide supplied as a laboratory reference material for secretagogue-signaling research.
What kind of research references Ipamorelin?
Preclinical pharmacology and cellular receptor-signaling studies of the growth-hormone-secretagogue pathway.
Is Ipamorelin approved for human or veterinary use?
No. Ipamorelin is not approved by the FDA or any regulatory authority for human or animal use. It is sold exclusively for in-vitro and laboratory research and is not for consumption.
How is the reference material characterized?
Each released lot is supplied as a lyophilized powder with a lot-specific certificate of analysis reporting HPLC purity of ≥ 99%. The certificate is tied to the specific released lot.
How should the compound be stored?
Lyophilized material is typically stored at -20°C, protected from light and moisture. Handling should follow standard laboratory practice for peptide reference materials. We do not provide reconstitution, dosing, or administration guidance.
- Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol (1998).
- Growth-hormone-secretagogue receptor pharmacology (review).
Links open a curated peer-reviewed search on PubMed. Allpointe Bio Research is not affiliated with the cited authors or publishers.
Research-Use Statement
The information above is provided for educational and scientific-reference purposes only and summarizes findings reported in the published preclinical and in-vitro literature. It is not medical advice and does not describe outcomes, benefits, or applications for humans or animals. Ipamorelin is supplied strictly as a laboratory reference material for in-vitro and research use only — it is not a drug or supplement, is not approved for human or veterinary use, and is not for consumption. Allpointe Bio Research does not provide clinical, dosing, reconstitution, or administration guidance.